Ronald C. Renaud Jr., President & CEO at Cerevel Therapeutics Holdings, Inc. (CERE), bought 167,714 shares at $23.96 ($4.0M) on 2023-08-03, disclosed to the SEC on 2023-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.96 | 83,857 | $2.0M | 50.0% |
| 2 | $23.96 | 83,857 | $2.0M | 50.0% |
| Total | $23.96 avg | 167,714 | $4.0M | 100% |
| Filing → |